Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Huang

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|July 20, 2022
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphomaQingyuan Zhang, Rong Tao, Zhenyu Li, et al.
Biochemical Pharmacology|February 5, 2021
The anti-melanogenic effects of ellagic acid through induction of autophagy in melanocytes and suppression of UVA-activated α-MSH pathways via Nrf2 activation in keratinocytesHsin-Ling Yang, Chia-Pei Lin, Yugandhar Vudhya Gowrisankar, et al.
Breast Cancer Research and Treatment|July 16, 2008
Three-dimensional pathological size assessment in primary breast carcinomaUwe Güth, Denise Brenckle, Dorothy Jane Huang, et al.
Future Oncology (London, England)|June 6, 2018
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemiaConstantine S Tam, Veronique LeBlond, William Novotny, et al.
Familial Cancer|September 5, 2013
Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancerFabienne Dominique Schwab, Nicole Bürki, Dorothy Jane Huang, et al.
Blood Advances|February 8, 2023
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemiaConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Oxidative Medicine and Cellular Longevity|July 4, 2020
Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NF<i>κ</i>B Signaling Pathways in Primary SplenocytesHsin-Ling Yang, Ting-Yu Yang, Yugandhar Vudhya Gowrisankar, et al.
Haematologica|April 21, 2022
A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinibAnthony R Mato, Boxiong Tang, Soraya Azmi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 20, 2024
Simulation of Changes in Tensile Strain by Airbag Impact on Eyes After Trabeculectomy by Using Finite Element AnalysisShuji Suzuki, Aya Ikeda, Takashi Uemura, et al.
Journal of Cosmetic Science|December 1, 2012
Crude ethanol extracts from grape seeds and peels exhibit anti-tyrosinase activityCheng-Kuang Hsu, Su-Tze Chou, Pai-Jane Huang, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|July 20, 2022
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphomaQingyuan Zhang, Rong Tao, Zhenyu Li, et al.
Biochemical Pharmacology|February 5, 2021
The anti-melanogenic effects of ellagic acid through induction of autophagy in melanocytes and suppression of UVA-activated α-MSH pathways via Nrf2 activation in keratinocytesHsin-Ling Yang, Chia-Pei Lin, Yugandhar Vudhya Gowrisankar, et al.
Breast Cancer Research and Treatment|July 16, 2008
Three-dimensional pathological size assessment in primary breast carcinomaUwe Güth, Denise Brenckle, Dorothy Jane Huang, et al.
Future Oncology (London, England)|June 6, 2018
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemiaConstantine S Tam, Veronique LeBlond, William Novotny, et al.
Familial Cancer|September 5, 2013
Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancerFabienne Dominique Schwab, Nicole Bürki, Dorothy Jane Huang, et al.
Blood Advances|February 8, 2023
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemiaConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Oxidative Medicine and Cellular Longevity|July 4, 2020
Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NF<i>κ</i>B Signaling Pathways in Primary SplenocytesHsin-Ling Yang, Ting-Yu Yang, Yugandhar Vudhya Gowrisankar, et al.
Haematologica|April 21, 2022
A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinibAnthony R Mato, Boxiong Tang, Soraya Azmi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 20, 2024
Simulation of Changes in Tensile Strain by Airbag Impact on Eyes After Trabeculectomy by Using Finite Element AnalysisShuji Suzuki, Aya Ikeda, Takashi Uemura, et al.
Journal of Cosmetic Science|December 1, 2012
Crude ethanol extracts from grape seeds and peels exhibit anti-tyrosinase activityCheng-Kuang Hsu, Su-Tze Chou, Pai-Jane Huang, et al.
Pageof 13